Skip to main content
padlock icon - secure page this page is secure

The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review

Buy Article:

Price: $68.00 + tax (Refund Policy)

SARS-CoV 2 is a novel virus strain of Coronavirus, which reported in China in late December 2019. Its highly contagious nature in humans has prompted WHO to designate the ongoing pandemic as a Public Health Emergency of International Concern. At this moment, there is no specific treatment and the therapeutic strategies to deal with the infection are only supportive, with prevention aimed at reducing community transmission. A permanent solution for the pandemic, which has brought the world economy to the edge of collapse, is the need of the hour. This situation has brought intense research in traditional systems of medicine. Indian Traditional System, Ayurveda, has a clear concept of the cause and treatment of pandemics. Through this review, information on the potential antiviral traditional medicines along with their immunomodulatory pathways is discussed. We have covered the seven most important Indian traditional plants with antiviral properties: Withaniasomnifera (L.) Dunal (family: Solanaceae), Tinosporacordifolia (Thunb.) Miers (family: Menispermaceae), Phyllanthusemblica L. (family: Euphorbiaceae), Asparagus racemosus L.(family: Liliaceae), Glycyrrhizaglabra L. (family: Fabaceae), Ocimum sanctum L.(family: Lamiaceae) and Azadirachta indica A. Juss (family: Meliaceae) in this review. An attempt is also made to bring into limelight the importance of dietary polyphenol, Quercetin, which is a potential drug candidate in the making against the SARS-CoV2 virus.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: ‘Ayurveda’; ‘COVID 19’; ‘Phytochemical’; ‘Traditional medicine’; Quercetin

Affiliations: Amrita School of Pharmacy, Amrita VishwaVidyapeetham, AIMS Health Science Campus, Ponekkara P.O., Kochi, Kerala 682041, India.

Appeared or available online: August 25, 2020

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more